Melissa Earl

560 total citations
15 papers, 429 citations indexed

About

Melissa Earl is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Melissa Earl has authored 15 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Melissa Earl's work include Glaucoma and retinal disorders (12 papers), Ocular Surface and Contact Lens (8 papers) and Retinal Diseases and Treatments (6 papers). Melissa Earl is often cited by papers focused on Glaucoma and retinal disorders (12 papers), Ocular Surface and Contact Lens (8 papers) and Retinal Diseases and Treatments (6 papers). Melissa Earl collaborates with scholars based in United States, United Kingdom and Australia. Melissa Earl's co-authors include Sue Ellen Cox, Steven Silverstein, Robert J. Noecker, John R. Wittpenn, John D. Hunkeler, Jeffrey S. Heier, Kenneth R. Kenyon, Steven T. Simmons, Robert D. Williams and John G. Walt and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Dermatologic Surgery.

In The Last Decade

Melissa Earl

14 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa Earl United States	10	267	129	113	108	96	15	429
Robert D. Gross United States	12	90 0.3×	130 1.0×	32 0.3×	46 0.4×	63 0.7×	21	331
Hossein Aghaei Iran	10	102 0.4×	91 0.7×	11 0.1×	57 0.5×	17 0.2×	40	308
J.–P. Nordmann France	10	197 0.7×	74 0.6×	8 0.1×	98 0.9×	24 0.3×	55	284
Jinho Jeong South Korea	7	392 1.5×	61 0.5×	5 0.0×	256 2.4×	34 0.4×	21	454
Silvana V. Araujo United States	9	351 1.3×	36 0.3×	9 0.1×	238 2.2×	20 0.2×	11	389
William C. Stewart United States	13	337 1.3×	123 1.0×	10 0.1×	149 1.4×	9 0.1×	21	370
Leopoldo Magacho Brazil	9	356 1.3×	59 0.5×	5 0.0×	197 1.8×	31 0.3×	40	371
Kin Sheng Lim United Kingdom	9	350 1.3×	138 1.1×	6 0.1×	171 1.6×	15 0.2×	24	425
Yoreh Barak Israel	9	172 0.6×	55 0.4×	10 0.1×	152 1.4×	33 0.3×	29	319
Yasin Toklu Türkiye	11	234 0.9×	46 0.4×	5 0.0×	215 2.0×	31 0.3×	33	325

Countries citing papers authored by Melissa Earl

Since Specialization

Citations

This map shows the geographic impact of Melissa Earl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Earl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Earl more than expected).

Fields of papers citing papers by Melissa Earl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Earl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Earl. The network helps show where Melissa Earl may publish in the future.

Co-authorship network of co-authors of Melissa Earl

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Earl. A scholar is included among the top collaborators of Melissa Earl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Earl. Melissa Earl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Walt, John G., et al.. (2010). Safety, Effectiveness, and Subjective Experience with Topical Bimatoprost 0.03% for Eyelash Growth. Dermatologic Surgery. 36(5). 638–649. 29 indexed citations

Nguyen, Quang H. & Melissa Earl. (2009). Fixed-Combination Brimonidine/Timolol as Adjunctive Therapy to a Prostaglandin Analog: A 3-Month, Open-Label, Replacement Study in Glaucoma Patients. Journal of Ocular Pharmacology and Therapeutics. 25(6). 541–544. 3 indexed citations

Wittpenn, John R., Steven Silverstein, Jeffrey S. Heier, et al.. (2008). A Randomized, Masked Comparison of Topical Ketorolac 0.4% Plus Steroid vs Steroid Alone in Low-Risk Cataract Surgery Patients. American Journal of Ophthalmology. 146(4). 554–560.e1. 111 indexed citations

Trattler, William, Robert J. Noecker, & Melissa Earl. (2008). A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension. Advances in Therapy. 25(3). 179–189. 5 indexed citations

Mundorf, Thomas K., Robert J. Noecker, & Melissa Earl. (2007). Ocular hypotensive efficacy of brimonidine 0.15% as adjunctive therapy with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension. Advances in Therapy. 24(2). 302–309. 11 indexed citations

Dirks, Monte S., Robert J. Noecker, Melissa Earl, et al.. (2006). A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Advances in Therapy. 23(3). 385–394. 37 indexed citations

Noecker, Robert J., et al.. (2006). Comparing bimatoprost and travoprost in black Americans. Current Medical Research and Opinion. 22(11). 2175–2180. 17 indexed citations

Mundorf, Thomas K., et al.. (2004). A Multicenter, Investigator–Masked, Randomized Comparison of the IOP–Lowering Efficacy of Bimatoprost 0.03% versus Travoprost 0.004% in African Americans with Glaucoma or Ocular Hypertension. 45(13). 4502–4502. 1 indexed citations

Earl, Melissa, et al.. (2004). The efficacy of bimatoprost 0.03% monotherapy in patients previously using topical beta-blocker monotherapy for the treatment of glaucoma or ocular hypertension. Advances in Therapy. 21(6). 370–379. 4 indexed citations

10.

Noecker, Robert J. & Melissa Earl. (2004). An update on bimatoprost (Lumigan^®) in glaucoma therapy. Therapy. 1(1). 31–41.

11.

Noecker, Robert J., et al.. (2003). Bimatoprost 0.03% versus travoprost 0.004% in Black Americans with glaucoma or ocular hypertension. Advances in Therapy. 20(2). 121–128. 30 indexed citations

12.

Cox, Sue Ellen, et al.. (2003). Social Implications of Hyperfunctional Facial Lines. Dermatologic Surgery. 29(5). 450–455. 35 indexed citations

13.

Cox, Sue Ellen, et al.. (2003). Social Implications of Hyperfunctional Facial Lines. Dermatologic Surgery. 29(5). 450–455. 92 indexed citations

14.

Simmons, Steven T. & Melissa Earl. (2002). Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on β-blockers. Ophthalmology. 109(2). 307–314. 34 indexed citations

15.

Albietz, Julie, et al.. (2002). A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients.. PubMed. 28(2). 96–100. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact